Paeoniflorin's Effects on Enzymes Related to Alzheimer's Disease
Author Information
Author(s): Mohnad Abdalla, Khalid Asaad, Hedayati Jasmine, Ghayur Muhammad Nabeel
Primary Institution: Pediatric Research Institute, Children's Hospital, Shandong University
Hypothesis
Paeoniflorin inhibits cholinesterase enzymes, potentially aiding in Alzheimer's treatment.
Conclusion
Paeoniflorin significantly inhibits both acetylcholinesterase and butyrylcholinesterase, suggesting its potential use in treating Alzheimer's disease.
Supporting Evidence
- Paeoniflorin inhibited AChE by 90.3% and BuChE by 99.4%.
- The EC50 for AChE was 0.52 mg/mL and for BuChE was 0.13 mg/mL.
- Molecular dynamics simulations showed stable interactions between paeoniflorin and both enzymes.
Takeaway
Paeoniflorin is a plant compound that can help stop certain enzymes that cause memory problems in Alzheimer's disease.
Methodology
The study used in vitro enzyme inhibition assays and molecular dynamics simulations to assess the effects of paeoniflorin on cholinesterase enzymes.
Statistical Information
P-Value
<0.0001
Confidence Interval
(0.18–1.52) for AChE, (0.08–0.21) for BuChE
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website